News and Comments


Prohost Biotech - Monday, July 29, 2013

Elan is Taken over by Perrigo in a transaction that involves cash and shares of Perrigo.  For the details of the transaction, the press release and the PDF presentation by the New Perrigo Prohost subscribers can click on TODAY'S HIGHLIGHTS at this Website. 

This transaction was predictable. Congratulation for Prohost subscribers who kept the stock even during the time when the stock had tumbled under tremendous pressure by the market evaluators.  

FORWARD-LOOKING: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.

Post has no comments.
Post a Comment

Captcha Image

Trackback Link
Post has no trackbacks.

Recent Postings



MODERNA AstraZeneca (AZN) Ziofpharm (ZIOP) ABBVIE (ABBV) Vertex (VRTX) Revlimid (lenolidamide) NEUROCRINE (NBIX) JOUNCE THERAPEUTICS (JNCE) ACADIA (ACAD) OncoCyte (OCX) Agenus (AGEN) Global Cell Therapeutics (GBT) Dynavax (DVAX) Elan (ELN) BIOMARIN (BMRN) Spike Therapeutics (ONCE) Theravance Bio Pharma (TBPH) Benlysta (belimumab) Xoma (XOMA) Roche (ROCHE) Dendreon (DNDN) Anacor (ANAC) Roche (RHHBY) Ionis (IONS) ZALTRAP™ Intermune (ITMN) Sequenom (SQNM) Theravance (THRX) Amgen (AMGN) Ariad (ARIA) RenenxBio (RGNX) Trastuzumab-DM1 Prolor Biotech (PBTH) Adaptimmune (ADAP) Biogen Idec (BIIB) PORTOLA (PTLA) REGULUS (RGLS) NEKTAR (NKTR)) Zerenex Human Longevity (HLI) GlaxoSmithKline (GSK) Idenix (IDIX) INNOVIVA (INVA) Sarepta (SRPT) NOVOCURE (NVCR) Ocular Therapeutix (OCUL) NANTKWEST (NK) Gilead (GILD) ADVENTRIX (ANX) Regeneron (REGN) Alnylam (ALNY) Bristol-Myers Squibb (BMY) Onyx (ONXX) Micromet (MITI) GlycoMimetics (GLYN) Galena (GALE) IDERA (IDRA) Seattle Genetics (SGEN) ImmunoGen (IMGN) Biocryst (BCRX) Exelixis (EXEL) KITE (KITE) Agenus (AGEN Sanofi (SNA) Merck (MRK) Sanofi-Aventis (SAN) SERES THERAPEUTICS (MCRB) Abbott Laboratories (ABT) Anadys (ANDS) Prosensa (RNA) Vitae Pharmaceuticals (VTAE) Ridaforolimus Mirati Therapeutics (MRTX) galapagos (GLPG) Velcade (bortezomib) VANDA (VNDA) Auspex (ASPX) Alder Biopharmaceuticals (ALDR) ISIS (ISIS) Epizyme (EPZM) TOKAI (TKAOI) Jazz Pharmaceuticals (JAZZ) PTC Therapeutics (PTCT) Sangamo (SGMO) Advaxis (ADXS) Array Pharmaceuticals (ARRY) Rapamune Valeant Pharmaceuticals International (VRX) Intercept (ICPT) Aimmune Therapeutics (AIMT) KERYX (KERX) HALOZYME (HALO) Akebia Therapeutics (AKAB) SYNTA (SNTA) ARGOS (ARGS) CRISPR Therapeutics (CRSP) ARCA (ABIO) C4 Therapeutics OSI (OSIP) AERIE PHARMACEUTICALS Genentech Illumina (ILMN) Human Genome Sciences (HGSI) SUNESIS PHARMACEUTICALS (SNSS) Telaprevir CEMPRA (CEMP) CompuGen (CGEN) Editas (EDIT) JUNO (JUNO) LEXICON (LXRX) Intrexon (XON) AGOS (ARGS) Sanofi (SNY) Pluristem (PSTI) Inovio (INO) Herceptin Multiple Myeloma GUARDIAN HEALTH Cytokinetics (CYTK) Bellicum (BLCM) Tysabri Incyte (INCY) Endometrial Cancer